Nerfin-1 represses transcriptional output of Hippo signaling in cell competition.
Pengfei GuoChang-Hyun LeeHuiyan LeiYonggang ZhengKatiuska Daniela Pulgar PrietoDuojia PanPublished in: eLife (2019)
The Hippo tumor suppressor pathway regulates tissue growth in Drosophila by restricting the activity of the transcriptional coactivator Yorkie (Yki), which normally complexes with the TEF/TEAD family DNA-binding transcription factor Scalloped (Sd) to drive the expression of growth-promoting genes. Given its pivotal role as a central hub in mediating the transcriptional output of Hippo signaling, there is great interest in understanding the molecular regulation of the Sd-Yki complex. In this study, we identify Nerfin-1 as a transcriptional repressor that antagonizes the activity of the Sd-Yki complex by binding to the TEA DNA-binding domain of Sd. Consistent with its biochemical function, ectopic expression of Nerfin-1 results in tissue undergrowth in an Sd-dependent manner. Conversely, loss of Nerfin-1 enhances the ability of winner cells to eliminate loser cells in multiple scenarios of cell competition. We further show that INSM1, the mammalian ortholog of Nerfin-1, plays a conserved role in repressing the activity of the TEAD-YAP complex. These findings reveal a novel regulatory mode converging on the transcriptional output of the Hippo pathway that may be exploited for modulating the YAP oncoprotein in cancer and regenerative medicine.
Keyphrases
- transcription factor
- dna binding
- genome wide identification
- induced apoptosis
- single cell
- poor prognosis
- cell cycle arrest
- gene expression
- cell therapy
- signaling pathway
- genome wide
- climate change
- oxidative stress
- dna methylation
- cell death
- stem cells
- binding protein
- mesenchymal stem cells
- bone marrow
- young adults
- network analysis
- genome wide analysis